
Release date: 2026-03-06 16:35:31 Article From: Lucius Laos Recommended: 242
The price of osimertinib varies depending on specifications, region, purchasing channels, and medical insurance policies. For specific prices in the domestic market, it is necessary to refer to the actual selling prices at hospitals or legitimate pharmacies. This medication is a prescription drug and must be used strictly under a doctor's guidance before administration.
Osimertinib is commonly available in 80mg and 40mg specifications, with the 80mg/30-tablet pack being the mainstream specification and priced higher. Some patients may need dose adjustments, which should be determined based on the doctor's advice.
Osimertinib has been included in China's medical insurance catalog (as of 2023). Patients who meet the indications can benefit from medical insurance reimbursement, with out-of-pocket expenses varying by regional policies. In some regions, the monthly out-of-pocket cost for patients can be reduced to below a thousand yuan.
Hospital Pharmacies: Prices are lower after medical insurance reimbursement, but eligibility for medication is required.
Retail Pharmacies: Prices may be slightly higher, and it is advisable to choose qualified and legitimate pharmacies.
Overseas Purchases: Some patients opt to purchase lower-priced generic versions from abroad, but this carries legal risks and potential counterfeit drug concerns, so caution is advised.
Lucius Pharmaceuticals Osimertinib is primarily used for patients with EGFR T790M mutation-positive non-small cell lung cancer. Genetic testing is required to confirm eligibility for the medication.
Some nonprofit organizations or pharmaceutical companies provide medication assistance to financially disadvantaged patients. Patients can consult their primary physician or the hospital's social work department for more information.
Side effects such as diarrhea and skin rashes may occur during medication use. Regular follow-ups and feedback on physical condition are necessary.
Important Note: Any adjustments to medication should only be made under the guidance of a doctor. Do not purchase or change the dosage independently. If there are any questions about costs or treatment efficacy, it is recommended to seek personalized treatment plans through legitimate medical institutions.
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended:[list:visits]2025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:[list:visits]2024-09-07
Lucius version of Dacomitinib is now availableCutaneous adverse reactions and management strategies ···【more】
Recommended:[list:visits]2026-21-07
Company Overview: Industrial Migration from India to LaosLucius Pharmaceuticals (Laos) Co., Ltd. was···【more】
Recommended:[list:visits]2026-20-07
Lucius Pharmaceutical is one of the representative generic drug enterprises in Laos. The company was···【more】
Recommended:[list:visits]2026-17-07
Industrial Rise: From Zero to a "World Pharmacy" CandidateThe explosive growth of Laos'···【more】
Recommended:[list:visits]2026-16-07
In recent years, Laos generic drugs have gradually come into view of oncology and chronic disease pa···【more】
Recommended:[list:visits]2026-15-07
Regulatory System: From "One Ministry, One Department" to Legal AmendmentsLao drug regulat···【more】
Recommended:[list:visits]2026-14-07

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com

Name: Lucius

Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643